Vyvgart 1000 mg/ 5.6 ml, solution injectable

7680697250013 CH-69725 Injektionslösung
Vyvgart 1000 mg/ 5.6 ml, solution injectable
Vyvgart 1000 mg/ 5.6 ml, solution injectable
Vyvgart 1000 mg/ 5.6 ml, solution injectable
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
30/07/2026
Summary of Product Characteristics
Français
30/07/2026
Summary of Product Characteristics
Italien
30/07/2026
Patient information leaflet
Allemand
28/05/2026
Patient information leaflet
Français
28/05/2026
Patient information leaflet
Italien
28/05/2026

Detailed composition

Substance Quantity Type Category
efgartigimodum alfa
1000.0 MG Substance Wirkstoff (Principe actif)
hyaluronidasum humanum ADNr
- Substance HNIDK
histidinum
- Substance HNIDK
histidini hydrochloridum monohydricum
- Substance HNIDK
dl-methioninum
- Substance HNIDK
natrii chloridum
- Substance HNIDK
natrium
12.9 MG Substance HBESI
saccharum
- Substance HNIDK
polysorbatum 20
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Authorization holder

argenx Switzerland SA

1214 Vernier

Authorization information

Swissmedic authorization number
69725
Drug name
Vyvgart, solution injectable
Galenic form
LSINJ
ATC Code
L04AL01
Authorization status
Z
Dispensing category
A
First authorization
10/02/2025
Authorization expiration date
09/02/2030
IT Number
07.15.0.
Domain
Human medicine

Package details

Description (FR)
VYVGART sol inj 1000 mg/5.6ml flac
Description (DE)
VYVGART Inj Lös 1000 mg/5.6ml Durchstf
Market launch
10/02/2025
Narcotic (BTM)
No
Buy us a coffee Explore the data